Start the conversation
Energy Advantage. For more active investors, he issues shorter-term trades in his Energy Inner Circle. And Kent's exclusive Micro Energy Trader is a "swing for the fences" service that targets micro-cap energy stocks. Oil & Energy Investor is Kent's e-letter, where he delivers the latest energy news from his travels around the world in his role as a consultant for major companies and governments.
The work he did laid the foundation for what would later become the VIX - to this day one of the most widely used indicators worldwide. After leaving Chicago to run the futures and options division of the British banking giant Lloyd's TSB, Shah moved up to Roosevelt & Cross Inc., an old-line New York boutique firm. There he originated and ran a packaged fixed-income trading desk, and established that company's "listed" and OTC trading desks.
Shah founded a second hedge fund in 1999, which he ran until 2003.
Shah's vast network of contacts includes the biggest players on Wall Street and in international finance. These contacts give him the real story - when others only get what the investment banks want them to see.
Today, as editor of Hyperdrive Portfolio, Shah presents his legion of subscribers with massive profit opportunities that result from paradigm shifts in the way we work, play, and live.
Shah is a frequent guest on CNBC, Forbes, and MarketWatch, and you can catch him every week on Fox Business's Varney & Co.
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance, and Nexus-9 Network.
William (Bill) Patalon III is the Executive Editor and Senior Research Analyst for Money Morning at Money Map Press. Before he moved into the investment-research business in December 2005, Bill spent 22 years as a journalist, most of it covering financial news as a reporter, columnist, and editor that included stints with Gannett Co. Inc., and The Baltimore Sun.
Bill has covered finance and investing, economics, manufacturing, the defense sector, biotechnology, and telecommunications. The companies he’s covered include Eastman Kodak, Xerox, Harley-Davidson, Caterpillar, Westinghouse Electric, Verizon, MedImmune, and Black & Decker.
His most-memorable interviews include: former President Richard M. Nixon, General Electric CEO John F. “Jack” Welch, Forbes magazine publisher and former Presidential candidate Steve Forbes, and business-turnaround specialist and helicopter-industry pioneer Stanley Hiller Jr.
It was Bill’s work covering Eastman Kodak Co., during the last half of the 1990s that solidified his reputation as one of the nation’s top analytical business journalists. With his award-winning reports on Kodak’s competitive travails, he consistently scooped his competitors in the national business media. His chronicles of Kodak’s turnaround efforts took him to China, Japan, Silicon Valley, New York, Washington, D.C., and even Hollywood.
His work has appeared in Kiplinger’s personal finance magazine, USA Today, and The South China Morning Post, among other publications. A winner of approximately two-dozen journalism awards – including top honors from The Associated Press and the prestigious Society of American Business Editors and Writers (SABEW). Patalon is also the co-author of the Prentice Hall book, "Contrarian Investing: How to Buy and Sell When Others Won’t and Make Money Doing It." Before taking over Money Morning, he served as the editor of The Rebound Report, an investment newsletter focusing on turnaround stocks.
Bill has a BA in Print Journalism from Penn State University, and an MBA in finance from the Rochester Institute of Technology.
Once singled out as the "most winning" stock-picker in the investment newsletter industry, Ernie Tremblay has more than 25 years of experience in following and analyzing the latest developments in health, medicine, and related technologies.
As a health editor and writer, he has contributed to more than 100 publications on topics like diabetes, Alzheimer's disease, arthritis, dermatology, and groundbreaking medical therapies, for top publishers such as Prentice Hall, Harper Collins, and others. Over the decades, Ernie has gained "insider" access to some of the world's top medical professionals, including Nobel-caliber doctors like Yale's Karel Liem, Columbia's George Gaylord Simpson, and Harvard's William S. Beck.
Ernie understands the FDA approval process, as well as the "hard science" behind new, experimental drugs and the market demand for them - and has a comprehensive grasp of the complex dynamics that determine whether a new drug will be a breakthrough winner, or just another casualty of the FDA approval process.
He puts that knowledge to work for members of his Biotech Insider Alert service, using a proprietary Three-Phase System that identifies the next "blockbuster" drugs and determines whether upcoming regulatory events will make a stock rocket skyward or plunge in the opposite direction . As a consulting editor for Money Map Press since 2012, Ernie's service has given readers opportunities to land substantial gains - including one bioscience stock that generated triple-digit gains four times in eight months.
D.R.Barton, Jr., Technical Trading Specialist for Money Map Press, is a world-renowned authority on technical trading with 25 years of experience. He spent the first part of his career as a chemical engineer with DuPont. During this time, he researched and developed the trading secrets that led to his first successful research service. Thanks to the wealth he was able to create for himself and his followers, D.R. retired early to pursue his passion for investing and showing fellow investors how to build toward financial freedom. Today, he's a financial author, lecturer, and coach. He has helped hundreds of thousands master powerful trading techniques. D.R. is also the co-founder and COO of the Directional Research and Trading hedge fund group and holds the national spotlight as a leading expert on system designs for risk reduction. D.R. co-authored the New York Times and Wall Street Journal best-selling book Safe Strategies for Financial Freedom, a comprehensive guide for aggressively shedding risk without derailing profits. He is a regular analyst on Fox Business, CNBC, Bloomberg Radio, and has been featured on China Central Television America, BNN, MarketWatch, Financial Advisor magazine, SmartMoney, and the Van Tharp Institute.
Tom Gentile, options trading specialist for Money Map Press, is known as America's No. 1 Pattern Trader.
But really, he's so much more than that.
Tom wasn't always so successful. Thirty years ago, he was just a kid working 60 hours a week at Home Depot, making the same amount every hour no matter how hard he worked.
It's a familiar story. But it jumpstarted Tom to do something different.
That's when his life really began to change. Tom began his career by studying the ins and outs of options trading every single night in his parent's basement back in 1986. Years later, he had built one of the largest financial tech companies showing people how to trade. It was called Optionetics, and it quickly established a stellar reputation in the field of options education.
In 2009, Tom sold Optionetics to one of the largest discount brokers in the world for millions of dollars.
Since then, he has dedicated his career to teaching people how to trade. Tom has taught over 300,000 traders his option trading secrets in a variety of settings, including seminars, workshops, and sponsored events like The Money Show. He's also a bestselling author of eight books and training courses.
Tom's personal mission in life is to show people like you everything he's learned in his 30 years of trading. He wants you to break out of the grueling nine-to-five cycle and achieve the abundant life you deserve.
A former portfolio adviser and a 20-year veteran of the resource market - with special expertise in energy, metals, and mining stocks - Peter uses the close contacts and connections he amassed over the years to exploit the moneymaking potential of every kind of commodity.
Peter travels around the world to dig up the latest and greatest profit opportunity, whether it's in gold, silver, oil, coal, potash, chromium, or even water. He has also contributed some of the most widely read and highly regarded investing articles on Money Morning.
Peter holds an MBA from McGill University.